Great Basin Scientific Receives FDA 510(k) Clearance for Stool Bacterial Pathogens Panel SALT LAKE CITY, July 13, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced it has received U. S. Food and Drug Administration (FDA)...

Data to be Presented at ASM Microbe 2017 Demonstrates the Efficacy of Great Basin’s Stool Bacterial Pathogens Panel SALT LAKE CITY, June 01, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today that it will present three posters describing the...

Great Basin Scientific Submits 510(k) Application to the FDA for Stool Bacterial Pathogens Panel SALT LAKE CITY, Dec. 19, 2016 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today the 510(k) submission for the Stool Bacterial Pathogens...

Great Basin Scientific Completes Clinical Trial for Stool Bacterial Pathogens Panel SALT LAKE CITY, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today the successful completion of the clinical trial of its...